It is well accepted that patients with ulcerative colitis (UC) are at increased risk of developing colorectal carcinoma. Since 1992, several studies have examined the hypothesis that patients with concomitant primary sclerosing cholangitis (PSC) are at significantly increased risk of developing colorectal cancer or dysplasia. The size, design, end points, and populations involved in these studies have varied but critical review suggests that colorectal cancer is more common in the setting of PSC. Although the data do not allow exact quantification of the increased relative risk, there are nevertheless implications, both for understanding disease pathogenesis and for clinical practice. </p
Background: Patients with inflammatory bowel disease (IBD) and concurrent primary sclerosing cholang...
Patients with long-standing inflammatory bowel disease (IBD) have an increased risk of colorectal ca...
Background: Patients with inflammatory bowel disease (IBD) and concurrent primary sclerosing cholang...
It is well accepted that patients with ulcerative colitis (UC) are at increased risk of developing ...
BACKGROUND and AIMS: Patients with ulcerative colitis and concomitant primary sclerosing cholangitis...
peer reviewedUlcerative ulcerative colitis (UC) is a chronic inflammatory bowel disease characterize...
BACKGROUND: Patients with inflammatory bowel disease (IBD) and concurrent primary sclerosing cholang...
Background & Aims: Patients with inflammatory bowel disease (IBD) and primary sclerosing cholangitis...
Background & Aims: Patients with inflammatory bowel disease (IBD) and primary sclerosing cholangitis...
Background & Aims: Patients with inflammatory bowel disease (IBD) and primary sclerosing cholangitis...
BACKGROUND: The association between ulcerative colitis (UC) and colorectal cancer (CRC) is well esta...
Background: Patients with inflammatory bowel disease (IBD) and concurrent primary sclerosing cholang...
The association between ulcerative colitis (UC) and colorectal cancer (CRC) is widely accepted, alth...
Background: Patients with inflammatory bowel disease (IBD) and concurrent primary sclerosing cholang...
Background: Patients with inflammatory bowel disease (IBD) and concurrent primary sclerosing cholang...
Background: Patients with inflammatory bowel disease (IBD) and concurrent primary sclerosing cholang...
Patients with long-standing inflammatory bowel disease (IBD) have an increased risk of colorectal ca...
Background: Patients with inflammatory bowel disease (IBD) and concurrent primary sclerosing cholang...
It is well accepted that patients with ulcerative colitis (UC) are at increased risk of developing ...
BACKGROUND and AIMS: Patients with ulcerative colitis and concomitant primary sclerosing cholangitis...
peer reviewedUlcerative ulcerative colitis (UC) is a chronic inflammatory bowel disease characterize...
BACKGROUND: Patients with inflammatory bowel disease (IBD) and concurrent primary sclerosing cholang...
Background & Aims: Patients with inflammatory bowel disease (IBD) and primary sclerosing cholangitis...
Background & Aims: Patients with inflammatory bowel disease (IBD) and primary sclerosing cholangitis...
Background & Aims: Patients with inflammatory bowel disease (IBD) and primary sclerosing cholangitis...
BACKGROUND: The association between ulcerative colitis (UC) and colorectal cancer (CRC) is well esta...
Background: Patients with inflammatory bowel disease (IBD) and concurrent primary sclerosing cholang...
The association between ulcerative colitis (UC) and colorectal cancer (CRC) is widely accepted, alth...
Background: Patients with inflammatory bowel disease (IBD) and concurrent primary sclerosing cholang...
Background: Patients with inflammatory bowel disease (IBD) and concurrent primary sclerosing cholang...
Background: Patients with inflammatory bowel disease (IBD) and concurrent primary sclerosing cholang...
Patients with long-standing inflammatory bowel disease (IBD) have an increased risk of colorectal ca...
Background: Patients with inflammatory bowel disease (IBD) and concurrent primary sclerosing cholang...